Concepedia

Theresa McDevitt

TM

8

Publications

340

Citations

8

H-Index

2005

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

University of California, San Francisco

Children's Hospital of Philadelphia

University of Pennsylvania

University of the Sciences

Theresa McDevitt is an author at Bristol-Myers Squibb (United States) specializing in medicine, cell biology, and drug discovery.

ORCID

Top concepts

Publications per year

2005–2015

8

Publications

8

Characterization of BMS-911543, a functionally selective small-molecule inhibitor of JAK2

Ashok V. Purandare, Theresa McDevitt, Han Wan et al. · Leukemia · 2011 · 77 citations

, , +10

Toll-like Receptor 2 (TLR2), Transforming Growth Factor-β, Hyaluronan (HA), and Receptor for HA-mediated Motility (RHAMM) Are Required for Surfactant Protein A-stimulated Macrophage Chemotaxis

Joseph P. Foley, David T. Lam, Hongmei Jiang et al. · Journal of Biological Chemistry · 2012 · 59 citations · Full text

Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ERα+ tumorigenesis

Szeman Ruby Chan, Charles G. Rickert, William Vermi et al. · Cell Death and Differentiation · 2013 · 50 citations · Full text

, , +13

Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative Neoplasms

Honghe Wan, Gretchen M. Schroeder, Amy C. Hart et al. · ACS Medicinal Chemistry Letters · 2015 · 39 citations · Full text

, , +14

Role of endogenous TGF-β in glucocorticoid-induced lung type II cell differentiation

Theresa McDevitt, Linda W. Gonzales, Rashmin C. Savani et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2006 · 36 citations

Rows per page

1–5 of 8